Mr. Robert Hill reports

EMERALD HEALTH THERAPEUTICS CLOSES $16.8 MILLION PROSPECTUS SALE

Emerald Health Therapeutics Inc. has closed its prospectus sale to a single Canadian institutional accredited investor (announced on May 15, 2018). Pursuant to the offering, the company has issued four million units at a price per unit of $4.20 for gross proceeds of $16.8-million.

Each unit consists of one common share of the company and one common share purchase warrant. Each warrant will entitle the investor to acquire one common share of the company at a price of $5.20 per warrant share for a period of 18 months following the closing of the offering. In the event that the closing sale price of the company's common shares on the TSX Venture Exchange or such other principal stock exchange on which the common shares are then listed is greater than $6.50 per common share for a period of 20 consecutive trading days at any time after the closing of the offering, the company may accelerate the expiry date of the warrants by giving notice to the investor, and in such case the warrants will expire on the 30th day after the date on which such notice is given by the company.

The units were offered by way of a shelf prospectus supplement filed in all of the provinces of Canada, except Quebec, pursuant to National Instrument 44-101 -- Short Form Prospectus Distributions.

The company intends to use the net proceeds of the offering to finance the completion of its recently acquired agro-biotech facility in Quebec, for working capital and for general corporate purposes.

The previously announced purchase by the investor of two million common shares from Emerald Health Sciences Inc., a control person of the company, at a price of $4.20 per share has also closed.

About Emerald Health Therapeutics Inc.

Emerald Health Therapeutics is a licensed producer under Canada's Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. Emerald is preparing to serve the anticipated legal Canadian adult-use cannabis market starting in 2018. Emerald owns 50 per cent of a joint venture with Village Farms International Inc. which is converting an existing 1.1-million-square-foot greenhouse in Delta, B.C., to grow cannabis.

We seek Safe Harbor.